2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[1-(2-hydroxyphenyl)-2-methyl-3-oxopropyl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid

Metabolite details

Identifier

DOIXBPWLDANPTA-UHFFFAOYSA-N

InChI Key

DOIXBPWLDANPTA-UHFFFAOYSA-N

IUPAC name

2-amino-5-[[1-(carboxymethylamino)-3-[1-(2-hydroxyphenyl)-2-methyl-3-oxopropyl]sulanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

Preferred name

2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-{[1-(2-hydroxyphenyl)-2-methyl-3-oxopropyl]sulfanyl}ethyl}-C-hydroxycarbonimidoyl)butanoic acid

INN name

—

Synonym

—

ChEBI

CHEBI:193897

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47